Results

Total Results: 2,146 records

Showing results for "factor".

21. Topic Suggestion Description | Effective Health Care Program
    effectivehealthcare.ahrq.gov/get-involved/nominated-topics/population-children-18-years-of-age-1-what-are-the-incidences-and-prevalences-of-non-inflammatory-pain-syndromes-eg-benign-hypermobility-syndrome-patellofemoral-stress-syndrome-fibromyalgia-and-growing-pain-in-children-and-ad
    January 30, 2009 - a) What is the diagnostic accuracy of antinuclear antibody (ANA) and rheumatoid factor (RF) for children … interventions you would like to see compared: What is the diagnositic accuracy of ANA and Rheumatoid factor … tell us how you heard about the Effective Health Care Program Antinuclear Antibody, Rheumatoid Factor

22. Transparency of Reporting Requirements Project: Management of Infertility | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/transparency-infertility/research-protocol
    September 03, 2016 - subfertile/infertile women by etiology (e.g., endometriosis), one addressing treatment strategies for male factor … for different etiologies (i.e., KQ 1, polycystic ovarian syndrome; KQ 2, endometriosis; KQ 4, tubal factor … body mass index (BMI), presence of other potential causes of female infertility, or presence of male factor … stage of endometriosis, presence of other potential causes of female infertility, or presence of male factor … are the comparative safety and effectiveness of available treatment strategies for couples with male factor

23. Empirical Evidence of Associations Between Trial Quality and Effect Size | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/trial-quality-effect-evidence/research
    June 21, 2011 - A factor analysis-based model suggested three distinct quality domains. … There was no statistically significant linear association of a summary scale or factor scores with effect

24. Executive summary_Comparative Effectiveness Review No. 264_Social and Structural Determinants of Maternal Morbidity and Mortality: An Evidence Map (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-264-maternal-morbidity-mortality-executive-summary.pdf
    December 01, 2023 - • Limited depth and quality of available research within each risk factor domain— including racism … intersecting social-structural determinants of health that is an exemplar of new approaches to risk factor … intersecting social-structural determinants of health that is an exemplar of new approaches to risk factor … Limited depth and quality of available research within each risk factor impeded our ability to outline

25. Transparency of Reporting Requirements: Management of Infertility (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/transparency-infertility_research-protocol.pdf
    September 02, 2016 - for different etiologies (i.e., KQ 1, polycystic ovarian syndrome; KQ 2, endometriosis; KQ 4, tubal factor … body mass index (BMI), presence of other potential causes of female infertility, or presence of male factor … reserve, race, BMI, presence of other potential causes of female infertility, or presence of male factor … reserve, race, BMI, presence of other potential causes of female infertility, or presence of male factor … : o ICSI (note that interventions and comparators may vary depending on underlying cause of male factor

26. CER 217 Management of Infertility Evidence Summary (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/cer-217-infertility-evidence-summary.pdf
    May 01, 2019 - The most common demographic factor associated with female infertility is “advanced reproductive age … 6 PCOS Endometriosis Unexplained Infertility Tubal or Peritoneal Factor KQ 1 KQ 2 KQ 3 KQ 4 … addressed outcomes after treatment for tubal or peritoneal factor infertility. … infertility (KQ 4); and male factor infertility (KQ 5). … Tubal factor infertility and perinatal risk after assisted reproductive technology.

27. CER 217 Management of Infertility Evidence Summary (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-217-infertility-evidence-summary.pdf
    May 01, 2019 - The most common demographic factor associated with female infertility is “advanced reproductive age … 6 PCOS Endometriosis Unexplained Infertility Tubal or Peritoneal Factor KQ 1 KQ 2 KQ 3 KQ 4 … addressed outcomes after treatment for tubal or peritoneal factor infertility. … infertility (KQ 4); and male factor infertility (KQ 5). … Tubal factor infertility and perinatal risk after assisted reproductive technology.

28. Musculoskeletal-Complaints-Tests-Children Surveillance (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/musculoskeletal-complaints-tests-children_surveillance.pdf
    January 08, 2013 - CER #50: Antinuclear Antibody, Rheumatoid Factor, and Cyclic-Citrullinated Peptide Tests for Evaluating … .................................................... 5 1 Antinuclear Antibody, Rheumatoid Factor … Introduction Comparative Effectiveness Review (CER) #50, Antinuclear Antibody, Rheumatoid Factor … we had also identified in our electronic search.7 That study reported the prevalence of Rheumatoid Factor … / or (rheumatoid adj factor*).ti,ab. 4 limit 3 to (english language and yr="2009 - 2013") 5 2 or

29. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/vte-prophyalaxis_research-protocol.pdf
    March 01, 2011 - Because of their decreased binding to platelet factor 4, LMWHs have a lower incidence of thrombocytopenia … Rivaroxaban is an oral factor Xa inhibitor that was approved by the FDA in July 2011 for VTE prophylaxis … Trauma is known to be a major risk factor for VTE. …  We will consider low-dose UFH, LMWHs, factor Xa inhibitors, direct thrombin inhibitors, and …  We will consider low-dose UFH, LMWHs, factor Xa inhibitors, direct thrombin inhibitors, and

30. Untitled (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/infertility_research-protocol.pdf
    October 12, 2015 - • Male)Factor KQ#5 KQ#6 ! … factor!infertility,!other!female!causes!of!infertility,!or! common!comorbidities!such!as! … factor!infertility,!presence!of! endometrioma,!other!female!causes!of!infertility,!or! common! … factor!infertility),!testicular!sperm!extraction,! vasectomy!reversal,!surgical!repair!of! … Tubal factor infertility and perinatal risk after assisted reproductive technology.

31. Comparative Effectiveness of Pharmacologic and Mechanical Prophylaxis of Venous Thromboembolism Among Special Populations | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/vte-prophyalaxis/research-protocol
    January 12, 2012 - Because of their decreased binding to platelet factor 4, LMWHs have a lower incidence of thrombocytopenia … Rivaroxaban is an oral factor Xa inhibitor that was approved by the FDA in July 2011 for VTE prophylaxis … Trauma is known to be a major risk factor for VTE. … We will consider low-dose UFH, LMWHs, factor Xa inhibitors, direct thrombin inhibitors, and mechanical … We will consider low-dose UFH, LMWHs, factor Xa inhibitors, direct thrombin inhibitors, and mechanical

32. CER 217 Disposition of Comments: Management of Infertility (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/cer-217-management-of-infertility-comments.pdf
    May 14, 2019 - Some of these concepts I am trying to bring out (IE ICIS works for male factor infertility) can be … IE start with ICIS works for male factor in the introduction and then state looking at subgroups IE … (Page 12, line 24) We have clarified that this is the most common demographic factor, not the most … We agree that the evidence supporting male factor infertility treatments is sparse. … We agree that the evidence supporting male factor infertility treatments is sparse.

33. CER 217 Disposition of Comments: Management of Infertility (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-217-management-of-infertility-comments.pdf
    May 14, 2019 - Some of these concepts I am trying to bring out (IE ICIS works for male factor infertility) can be … IE start with ICIS works for male factor in the introduction and then state looking at subgroups IE … (Page 12, line 24) We have clarified that this is the most common demographic factor, not the most … We agree that the evidence supporting male factor infertility treatments is sparse. … We agree that the evidence supporting male factor infertility treatments is sparse.

34. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/musculoskeletal-complaints-tests-children_research-protocol.pdf
    September 29, 2010 - Evidence-based Practice Center Systematic Review Protocol Project Title: Antinuclear Antibody, Rheumatoid Factor … or limb or joint swelling may use serological tests such as antinuclear antibody (ANA), rheumatoid factor … The rheumatoid factor (RF) test is the most commonly used serological test to determine the presence … Rheumatoid factor and anti-CCP autoantibodies in rheumatoid arthritis: A review. … • Rheumatoid factor test (RF): The measure of serum level of rheumatoid factor antibody which is

35. Effective Health Care (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0319_06-17-2009.pdf
    January 01, 2009 - fibrinogen, leukocyte count, prothrombin time, partial thrombin time, interleukin 6, and tumor necrosis factor … fibrinogen, leukocyte count, prothrombin time, partial thrombin time, interleukin 6, and tumor necrosis factor

36. Treatment of Osteoarthritis of the Knee: An Update | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/osteoarthritis-knee-update/research-protocol
    June 16, 2016 - natural joint lubricant, hyaluronic acid (HA), experimental use of biologic agents (anti-nerve growth factor … antibodies or anti-tumor necrosis factor antibodies, which are used to treat rheumatoid arthritis), … anakinra OR canakinumab OR "platelet rich plasma" OR "platelet-rich plasma" OR PRP OR "nerve growth factor … 'platelet-rich plasma'/exp OR 'platelet-rich plasma' OR 'prp' OR 'prp'/exp OR prp OR 'nerve growth factor … '/exp OR 'nerve growth factor' OR (('fibroblast' OR 'fibroblast'/exp OR fibroblast) AND ('growth' OR

37. Treatment of Osteoarthritis of the Knee: An Update (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/osteoarthritis-knee-update_research-protocol.pdf
    June 15, 2016 - natural joint lubricant, hyaluronic acid (HA), experimental use of biologic agents (anti-nerve growth factor … antibodies or anti-tumor necrosis factor antibodies, which are used to treat rheumatoid arthritis), … FDA- CMS National Coverage Determination: Plasma AAOS: unable to recommend for or against growth factor … '/exp OR 'nerve growth factor' OR (('fibroblast' OR 'fibroblast'/exp OR fibroblast) AND ('growth' OR … '/exp OR 'nerve growth factor' OR ('fibroblast' OR 'fibroblast'/exp OR fibroblast AND ('growth' OR '

38. S116 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/s116.pdf
    October 01, 2007 - This factor will be a valid IV if: (1) physicians vary in their preference for using the 2 different … The reported prevalence difference (PD) is the prev- alence of the risk factor among patients started … on an atypical APM minus the prevalence of the risk factor among patients started on a conventional … The reported PD for the IV is the prevalence of the risk factor among patients of physicians who have … †Prevalence of risk factor among atypical users minus prevalence of risk factor among conventional users

39. Digestive Diseases | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/health-topics/digestive-diseases
    May 20, 2013 - Archived December 13, 2005 Comparative Effectiveness of In-Hospital Use of Recombinant Factor

40. Layout 1 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-biopsy-executive.pdf
    December 01, 2009 - intended to evaluate the accuracy of different methods of performing breast biopsy and to explore what factor … factors on accuracy and harms Strength of evidence Impact on Impact on supporting the Category Factor … improves Insufficient data Insufficient experience with experience Insufficient data for any other factor … category Factor Level of evidence factor on accuracy Patient characteristics Patient age Insufficient … on Factor category Factor Level of evidence harms Patient characteristics Patient age Insufficient